Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShort-Term Debt repayments
Ratios

bioAffinity Technologies (BIAF) Leases (2023 - 2025)

bioAffinity Technologies (BIAF) has disclosed Leases for 3 consecutive years, with $367398.0 as the latest value for Q3 2025.

  • On a quarterly basis, Leases fell 25.58% to $367398.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $367398.0, a 25.58% decrease, with the full-year FY2024 number at $1.3 million, up 11.01% from a year prior.
  • Leases was $367398.0 for Q3 2025 at bioAffinity Technologies, down from $565030.0 in the prior quarter.
  • In the past five years, Leases ranged from a high of $1.3 million in Q3 2023 to a low of $367398.0 in Q3 2025.
  • A 3-year average of $911153.0 and a median of $1.2 million in 2023 define the central range for Leases.
  • Peak YoY movement for Leases: rose 11.01% in 2024, then plummeted 66.64% in 2025.
  • bioAffinity Technologies' Leases stood at $1.2 million in 2023, then rose by 11.01% to $1.3 million in 2024, then tumbled by 71.61% to $367398.0 in 2025.
  • Per Business Quant, the three most recent readings for BIAF's Leases are $367398.0 (Q3 2025), $565030.0 (Q2 2025), and $431746.0 (Q1 2025).